Inflammatory markers and metabolic syndrome among adolescents

European Journal of Clinical Nutrition

Volumn 66, Issue 10, 2012, Pages 1141-1145

  Gonzalez M ^a   Del Mar Bibiloni, M ^a   Pons, A ^a   Llompart, I ^a   Tur, J A ^a  

^a UNIVERSITAT DE LES ILLES BALEARS   (Spain)

Author keywords

adiponectin; adolescents; leptin; metabolic syndrome; PAI 1

Indexed keywords

ADIPONECTIN; C REACTIVE PROTEIN; INTERLEUKIN 6; LEPTIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ANTHROPOMETRY; ARTICLE; BLOOD PRESSURE; BODY HEIGHT; BODY MASS; BODY WEIGHT; CHILD; FEMALE; HEALTH STATUS; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PHYSICAL ACTIVITY; SCHOOL CHILD; WAIST CIRCUMFERENCE;

ADIPONECTIN; ADOLESCENT; BIOLOGICAL MARKERS; BODY MASS INDEX; C-REACTIVE PROTEIN; CHILD; CROSS-SECTIONAL STUDIES; DOWN-REGULATION; FEMALE; HUMANS; HYPERTENSION; INFLAMMATION MEDIATORS; LEPTIN; MALE; MEDITERRANEAN ISLANDS; METABOLIC SYNDROME X; OVERWEIGHT; PLASMINOGEN ACTIVATOR INHIBITOR 1; PREDICTIVE VALUE OF TESTS; PREVALENCE; SPAIN; UP-REGULATION;

EID: 84867103669     PISSN: 09543007     EISSN: 14765640     Source Type: Journal    
DOI: 10.1038/ejcn.2012.112     Document Type: Article

References (51)

1. Fu JF, Liang L, Zou CC, Hong F, Wang CL, Wang XM et al. Prevalence of the metabolic syndrome in Zhejiang Chinese obese children and adolescents and the effect of metformin combined with lifestyle intervention. Int J Obes 2007; 31: 15-22.
2. Ji CY, Cheng TO. Epidemic increase in overweight and obesity in Chinese children from 1985 to 2005. Int J Cardiol 2009; 132: 1-10.
3. Alikaŝifog? lu A, Gönĉ EN, Ozön ZA, Sen Y, Kandemir N. The relationship between serum adiponectin, tumour necrosis factor-alpha, leptin levels and insulin sensitivity in childhood and adolescent obesity: adiponectin is a marker of metabolic syndrome. J Clin Res Pediatr Endocrinol 2009; 1: 233-239.
4. Cheung BM, Wat NM, Tam S, Thomas GN, Leung GM, Cheng CH et al. Components of the metabolic syndrome predictive of its development: a 6-year longitudinal study in Hong Kong Chinese. Clin Endocrinol 2008; 68: 730-737.
5. Johnson WD, Kroon JJM, Greenway FL, Bouchard C, Ryan D, Katzmarzyk PT. Prevalence of risk factors for metabolic syndrome in adolescents: national health and nutrition examination survey NHANES), 2001-2006. Arch Pediatr Adol Med 2009; 163: 371-377.
6. Weiss R, Dziura J, Burgert TS, Tamborlane WV, Taksali SE, Yeckel CW et al. Obesity and the metabolic syndrome in children and adolescents. N Engl J Med 2004; 350: 2362-2374.
7. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005; 112: 2735-2752.
8. Okamoto Y, Kihara S, Funahashi T, Matsuzawa Y, Libby P. Adiponectin: a key adipocytokine in metabolic syndrome. Clin Sci 2006; 110: 267-268.
9. Trujillo ME, Scherer PE. Adiponectin-journey from an adipocyte secretory protein to biomarker of the metabolic syndrome. J Int Med 2005; 257: 167-175.
10. Winer JC, Zern TL, Taksali SE, Dziura J, Cali AM, Wollschlager M et al. Adiponectin in childhood and adolescent obesity and its association with inflammatory markers and components of the metabolic syndrome. J Clin Endocrinol Metabol 2006; 91: 4415-4423.
11. Pyrzak B, Ruminska M, Popko K, Demkow U. Adiponectin as a biomarker of the metabolic syndrome in children and adolescents. Eur J Med Res 2010; 15: 147-151.
12. Jéquier E. Leptin signaling, adiposity, and energy balance. Lipids and insulin resistance: the role of fatty acid metabolism and fuel partitioning. Ann NY Acad Sci 2002; 967: 379-388.
13. Moran O, Phillip M. Leptin: obesity, diabetes and other peripheral effects-a review. Pediat Diab 2003; 4: 101-109.
14. Giordano P, Del Vecchio GC, Cecinati V, Delvecchio M, Altomare M, De Palma F et al. Metabolic, inflammatory, endothelial and haemostatic markers in a group of Italian obese children and adolescents. Eur J Pediat 2011; 170: 845-850.
15. Chou YY, Sheu WHH, Tang YJ, Chen YM, Liao SC, Chuang YW et al. Plasminogen activator inhibitor type 1 MS) in institutionalized elderly residents in Taiwan. Arch Gerontol Geriat 2009; 49: S41-S45.
16. Galli-Tsinopoulou A, Grammatikopoulou MG, Stylianou C, Emmanouilidou E, Kokka P. Diabese youngsters have 3.7 more chances in developing metabolic syndrome compared with the obese. J Endocrinol Inv 2010; 33: 549-553.
17. Wilson PW, D'Agostino RB, Parise H, Sullivan L, Meigs JB. Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation 2005; 112: 3066-3072.
18. Jiamsripong P, Mookadam M, Honda T, Khandheria BK, Mookadam F. The metabolic syndrome and cardiovascular disease: part I. Prev Cardiol 2008; 11: 155-161.
19. Torres JL, Ridker PM. Clinical use of high sensitivity C-reactive protein for the prediction of adverse cardiovascular events. Curr Opin Cardiol 2003; 18: 471-478.
20. Juhan-Vague I, Pyke SD, Alessi MC, Jespersen J, Haverkate F, Thompson SG. Fibrinolytic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. ECAT Study Group. European concerted action on thrombosis and disabilities. Circulation 1996; 94: 2057-2063.
21. Bibiloni M, Mart?́nez E, Llull R, Maffiotte E, Riesco M, Llompart I et al. Metabolic syndrome in adolescents in the Balearic Islands, a Mediterranean region. Nutr Metab Cardiovasc Dis 2011; 21: 446-454.
22. IPAQ - International Physical Activity Questionnaire. Guidelines for data processing and analysis of the International Physical Activity Questionnaire IPAQ). http://www.ipaq.ki.es/
23. Hagströmer M, Bergman P, De Bourdeaudhuij I, Ortega FB, Ruiz JR, Manios Y et al. Concurrent validity of a modified version of the International Physical Activity Questionnaire (IPAQ-A) in European adolescents: the HELENA study. Int J Obes 2008; 32: 542-548.
24. Vicente-Rodriguez G, Rey-López JP, Mart?́n-Mantillas M, Moreno LA, Wärnberg J, Redondo C et al. Television watching, videogames, and excess of body fat in Spanish adolescents: the AVENA study. Nutrition 2008; 24: 654-662.
25. Food and Nutrition Board, Institute of Medicine of the National Academies. Dietary Reference Intakes. Chapter 12, Physical Activity. The National Academies Press: Washington, DC, 2005, pp 880-935.
26. De Ferranti SD, Gauvreau K, Ludwig DS, Neufeld EJ, Newburger JW, Rifai N. Prevalence of the metabolic syndrome in American adolescents: findings from the Third National Health and Nutrition Examination Survey. Circulation 2004; 110: 2494-2497.
27. National Cholesterol Education Program (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults Adult Treatment Panel III) final report. Circulation 2002; 106: 3143-3421.
28. Serra L, Aranceta J, Pérez C, Moreno B, Tojo R, Delgado A. Grupo colaborativo AEPSENC- SEEDO. Curvas de referencia para la tipificación ponderal. IM&C, S.A.: Madrid, 2002.
29. National High Blood Pressure Education Program Working Group on Hypertension Control in Children and Adolescents. Update on the 1987 Task Force Report on High Blood Pressure in Children and Adolescents: a working group report from the National High Blood Pressure Education Program. Pediatrics 1996; 98: 649-658.
30. Eisenmann JC. One the use of a continuous metabolic syndrome score in pediatric research. Cardiovasc Diabetol 2008; 7: 17-22.
31. Camhi SM, Kuo J, Young DR. Identifying adolescent metabolic syndrome using body mass index and waist circumference. Prev Chronic Dis 2008; 5: 115-123.
32. Cali AMG, Caprio S. Obesity in children and adolescents. J Clin Endocrinol Metab 2008; 93: 31-36.
33. Liao CC, Su TC, Chien KL, Wang JK, Chiang CC, Ling CC et al. Elevated blood pressure, obesity, and hyperlipidemia. J Pediatr 2009; 155: 79-83.
34. Wu Y. Overweight and obesity in China. Br Med J 2006; 333: 362-363.
35. Trayhurn P, Beattie JH. Physiological role of adipose tissue: white adipose as an endocrine and secretory organ. Proc Nut Soc 2001; 60: 329-339.
36. Rothenbacher D, Brenner H, Marz W, Koenig W. Adiponectin risk of coronory artery disease and correlations with cardiovascular risk markers. Eur Heart J 2005; 26: 1640-1646.
37. Pischon T, Girman CJ, Hotamisligil GS, Rifai N, Hu FB, Rimm EB. Plasma adiponectin levels and risk of myocardial infarction in men. JAMA 2004; 291: 1730-1737.
38. Diez JJ, Iglesias P. The role of the novel adipocyte-derived hormone adiponectin in human disease. Eur J Endocrinol 2003; 148: 293-300.
39. Fang X, Sweeney G. Mechanisms regulating energy metabolism by adiponectin in obesity and diabetes. Biochem Soc Trans 2006; 34: 798-801.
40. Shargorodsky M, Boaz M, Goldberg Y, Matas Z, Gavish D, Fux A et al. Adiponectin and vascular properties in obese patients: is it a novel biomarker of early atherosclerosis? Int J Obes 2009; 33: 553-558.
41. Hotta K, Funahashi T, Arita Y, Takahashi M, Matsuda M, Okamoto Y et al. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 2000; 20: 1595-1599.
42. Winer JC, Zern TL, Taksali SE, Dziura J, Cali AMG, Wollschlager M et al. Adiponectin in childhood and adolescent obesity and its association with inflammatory markers and components of the metabolic syndrome. J Clin Endocrinol Metab 2006; 91: 4415-4423.
43. Ogawa Y, Kikuchi T, Nagasaki K, Hiura M, Tanaka Y, Uchiyama M. Usefulness of serum adiponectin level as a diagnostic marker of metabolic syndrome in obese Japanese children. Hypertens Res 2005; 28: 51-57.
44. Gilardini L, McTernan PG, Girola A, da Silva NF, Alberti L, Kumar S et al. Adiponectin is a candidate marker of metabolic syndrome in obese children and adolescents. Atherosclerosis 2006; 189: 401-407.
45. Saltevo J, Vanhala M, Kautiainen H, Kumpusalo E, Laakso M. Gender differences in C-reactive protein, interleukin-1 receptor antagonist and adiponectin levels in the metabolic syndrome: a population-based study. Diabet Med 2008; 25: 747-750.
46. Moran O, Phillip M. Leptin: obesity, diabetes and other peripheral effects - a review. Pediatr Diabetes 2003; 4: 101-109.
47. Antunes H, Santos C, Carvalho S. Serum leptin levels in overweight children and adolescents. Br J Nutr 2009; 101: 1262-1266.
48. Tammelin T, Näyhä S, Laitinen J, Rintamäki H, Jä rvelin MR. Physical activity and social status in adolescence as predictors of physical inactivity in adulthood. Prev Med 2003; 37: 375-381.
49. Motl RW, McAuley E, DiStefano C. Is social desirability associated with self-reported physical activity? Prev Med 2005; 40: 735-739.
50. Ekelund U, Neovius M, Linné Y, Brage S, Wareham NJ, Rö ssner S. Associations between physical activity and fat mass in adolescents: the Stockholm Weight Development Study. Am J Clin Nutr 2005; 81: 355-360.
51. Lazarou C, Panagiotakos DB, Kouta C, Matalas AL. Dietary and other lifestyle characteristics of Cypriot school children: results from the nationwide CYKIDS study. BMC Public Health 2009; 9: 147.